DVM-270 News: “Rockville lab to begin trials in attempt to cure HIV”

DVM-270 News: Rockville lab to begin trials in attempt to cure HIV
DC News Now features AGT's recent announcement that it was cleared by the FDA for phase 1 clinical trials of AGT103-T
Subscribe to our YouTube Channel

Written by: Shennekia Grimshaw

ROCKVILLE, Md. (WDVM) — As millions of people around the world are infected with HIV, a Rockville company believes it might be close to finding a cure.

American Gene Technologies got the green light by the Food and Drug Administration to begin phase one trials starting with six infected people. The company uses technology and a cell treatment therapy to develop a system that is supposed to work on HIV patients who have been on medication to control the virus for at least three years.

Once trials begin it will take nine months to determine if the company’s method actually works. Health officials say nearly 38 million people have been infected with HIV and over one million people in the United States are currently living with the disease. Maryland ranks fifth of all U.S. States in HIV diagnosis rates, with nearly 1,000 new cases in 2018 alone, according to the Maryland State Department of Health.

“Our scientific team has very high confidence that this has the potency to give HIV infected individuals a functional cure and the critical thing that’s happened right now is that the FDA is allowing us to do a trial,” said Jeff Galvin, American Gene Technologies, CEO.

Trials will start next month in Baltimore.

View The Original Article

This page is a replication of the original content. To respect the original publisher, this page is not indexed by search engines. The original article can be viewed by clicking the button below.

Subscribe to Press Release and News Updates

Subscribe to our press release and published article updates to be notified when we release new content!